2
Views
1
CrossRef citations to date
0
Altmetric
Review

Cross-border reproductive treatment with oocyte donation: what comes next?

, , &
Pages 41-47 | Published online: 10 Jan 2014
 

Abstract

Cross-border oocyte donation is a growing phenomenon that raises serious social, economical, ethical, medical, legal and political issues. There are implications for the patient, the unborn child, the donor, the home country, the destination country, human society, and the field of reproductive medicine. Actions should be taken in order to avoid the negative future consequences and to supplement the deficient frame of legislation and recorded data. The role of the professional societies, in this context, is of great importance and should be highlighted. Education and control of the reproductive care professionals, as well as access to information and international dialogue, are also essential, among other suggestions.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.